Cerus
CERS
$1.71
Share price
0.59%
Change (1 day)
-25.33%
Change (1 year)
Categories
Operating Margin for Cerus (CERS)
Operating Margin as of April 2024 (TTM): -41.30%
According to Cerus's latest financial reports and stock price the company's current Operating Margin is -41.30%. At the end of 2021 the company had an Operating Margin of -41.31%.
Operating Margin history for Cerus from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -41.31% | -36.26% |
| 2020 | -64.81% | -31.84% |
| 2019 | -95.09% | 1.01% |
| 2018 | -94.13% | -27.67% |
| 2017 | -130.14% | -22.86% |
| 2016 | -168.71% | -3.03% |
| 2015 | -173.97% | 64.3% |
| 2014 | -105.89% | -2.61% |
| 2013 | -108.73% | 154.54% |
| 2012 | -42.72% | -16.88% |
| 2011 | -51.39% | -29.77% |
| 2010 | -73.18% | -42.77% |
| 2009 | -127.86% | -30.87% |
| 2008 | -184.95% | -52.68% |
| 2007 | -390.85% | 2809.94% |
| 2006 | -13.43% | -64.96% |
| 2005 | -38.33% | -77.75% |
| 2004 | -172.27% | 275.68% |
| 2003 | -45.86% | -93.19% |
| 2002 | -673.64% | -37.99% |
| 2001 | -1,086.37% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 11.27% | -127.29% | 🇺🇸 USA |
 Utah Medical Products UTMD | 40.48% | -198.01% | 🇺🇸 USA |
 Haemonetics HAE | 12.09% | -129.27% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.